Summary
The Cigna Group has announced the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC) for approximately $3.7 billion. This divestiture is expected to result in an estimated pre-tax loss of $1.5 billion as of December 31, 2023, primarily due to asset write-offs and costs associated with the sale. Notably, this loss will not impact Cigna's adjusted income from operations or adjusted income from operations per share for the fourth quarter of 2023. The transaction is anticipated to close in the first quarter of 2025, subject to regulatory approvals and customary closing conditions. While the sale represents a significant strategic move, investors should monitor the progress of regulatory approvals and the eventual impact on Cigna's future operational focus and financial performance.
Key Highlights
- 1Cigna to sell Medicare Advantage, Supplemental Benefits, Medicare Part D, and CareAllies businesses to HCSC.
- 2Total transaction value is approximately $3.7 billion.
- 3Estimated pre-tax loss of $1.5 billion to be recognized as of December 31, 2023, primarily from asset write-offs and sale costs.
- 4The pre-tax loss will not affect Q4 2023 adjusted income from operations or adjusted income from operations per share.
- 5Expected closing date for the transaction is the first quarter of 2025.
- 6Transaction is subject to regulatory approvals and customary closing conditions.